Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Alison K. Esser, Daniel A. Rauch, Jingyu Xiang, John C. Harding, Nicole A. Kohart, Michael H. Ross, Xinming Su, Kevin Wu, Devra Huey, Yalin Xu, Kiran Vij, Patrick L. Green, Thomas J. Rosol, Stefan Niewiesk, Lee Ratner, Katherine N. Weilbaecher
Published Aug 27, 2017 · Vol. 8, No. 41 · pp. 69250-69263
Vijay Pandey, Min Zhang, Qing-Yun Chong, Mingliang You, Ainiah Rushdiana Raquib, Amit K. Pandey, Dong-Xu Liu, Liang Liu, Lan Ma, Sudhakar Jha, Zheng-Sheng Wu, Tao Zhu, Peter E. Lobie
Published Aug 24, 2017 · Vol. 8, No. 44 · pp. 77268-77291
Kai-Jie Yu, Jeffrey K. Li, Yu-Chen Lee, Guoyu Yu, Song-Chang Lin, Tianhong Pan, Robert L. Satcher, Mark A. Titus, Li-Yuan Yu-Lee, Wen Hui Weng, Gary E. Gallick, Sue-Hwa Lin
Published Aug 24, 2017 · Vol. 8, No. 43 · pp. 74987-75006